Gabelli Dividend & Income Trust Rebuts Saba Capital's Claims in Proxy Battle
Summary
The Gabelli Dividend & Income Trust has issued additional proxy materials, directly refuting claims made by activist investor Saba Capital Management regarding board independence, trustee alignment, fund performance, and governance structure ahead of its adjourned annual meeting.
Key Events
-
Proxy Battle Intensifies
The fund has released additional proxy materials, directly responding to claims made by activist investor Saba Capital Management ahead of the adjourned annual meeting on June 29, 2026.
-
Defense of Board Independence and Alignment
GDV asserts its board has ten independent trustees and highlights significant share ownership by Mr. Gabelli and other trustees, contrasting it with Saba's nominee owning no shares and Saba itself selling shares.
-
Rebuttal on Fund Performance
The fund refutes Saba's claims of widening discounts and excessive fees, presenting data that its discount has narrowed and its expense ratio is lower than peers, citing independent proxy advisors.
-
Governance Structure Defended
GDV defends its voting thresholds for nominees, the voting structure involving preferred shares, and its staggered board terms as common for closed-end funds and promoting stability.
Analysis
This filing is a direct and detailed rebuttal by Gabelli Dividend & Income Trust (GDV) to the claims made by activist investor Saba Capital Management. It is a significant development in the ongoing proxy contest, providing GDV's arguments on critical issues such as board independence, trustee share ownership, fund performance (discount and expense ratio), and governance structure. The company is actively campaigning for shareholder votes ahead of its adjourned annual meeting on June 29, 2026. The outcome of this proxy fight could lead to changes in the fund's board composition and potentially its management strategy.
At the time of this filing, GDV was trading at $28.77 on NYSE in the Unknown sector, with a market capitalization of approximately $2.5B. The 52-week trading range was $25.50 to $29.58. This filing was assessed with neutral market sentiment and an importance score of 8 out of 10.